| Serial Number | 97231267 |
| Word Mark | NEWGENE |
| Filing Date | Friday, January 21, 2022 |
| Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
| Status Date | Monday, July 20, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Pseudo Mark | NEW GENE |
| Goods and Services | Apparatus for magnet therapy; Blood testing apparatus; Body composition analyzers for medical purposes; Body composition monitors; Electrotherapy devices for providing transcutaneous electrical nerve stimulation, infrared heat and compression; Inhalers for medical use; Needles for medical purposes; Surgical apparatus and instruments for medical, dental or veterinary use; Syringes for medical purposes; Urological imaging systems |
| Translation of Words in Mark | The wording NEWGENE has no meaning in a foreign language. |
| Description of Mark | The mark consists of the stylized wording "NEWGENE". |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 26, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | Wednesday, December 1, 2021 |
| First Use In Commerce Date | Wednesday, December 1, 2021 |
| Party Name | New Gene (Hangzhou) Bioengineering Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Hangzhou, Zhejiang, 310000 CN |
| Event Date | Event Description |
| Tuesday, January 25, 2022 | NEW APPLICATION ENTERED |
| Wednesday, January 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 7, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Friday, July 7, 2023 | WITHDRAWAL OF ATTORNEY GRANTED |
| Monday, July 20, 2026 | ASSIGNED TO EXAMINER |